The Medtronic Kappa® DR 400 Series are dual-chamber pacemakers with two pacing leads, one in the atrium and one in the ventricle. These rate-responsive pacemakers have two sensors that detect changes in your heart rate needs. Based on these changes, your heart rate is adjusted accordingly.

The Cylos 990 family is unique among the competition due to its proven rate adaptive technology known as Closed Loop Stimulation (CLS). The CLS concept offers distinct clinical advantages over other rate-adaptive device algorithms because of its ability to deliver a more physiologic heart rate therapy depending on the metabolic needs of the individual patient.

The Cylos 990 family is unique among the competition due to its proven rate adaptive technology known as Closed Loop Stimulation (CLS). The CLS concept offers distinct clinical advantages over other rate-adaptive device algorithms because of its ability to deliver a more physiologic heart rate therapy depending on the metabolic needs of the individual patient.

The Cylos 990 family is unique among the competition due to its proven rate adaptive technology known as Closed Loop Stimulation (CLS). The CLS concept offers distinct clinical advantages over other rate-adaptive device algorithms because of its ability to deliver a more physiologic heart rate therapy depending on the metabolic needs of the individual patient.

The Kappa® DR900 pacemakers are dual-chamber pacemakers with two pacing leads, one in the atrium and one in the ventricle. The power of Kappa 900 is its ability to assist the physician in making patient and arrhythmia management decisions.

Features:

Monitoring and diagnostic capabilities that you’ve never seen before…that are designed to help you answer your most critical questions:

What types of arrhythmias are present?

The Kappa® DR900 pacemakers are dual-chamber pacemakers with two pacing leads, one in the atrium and one in the ventricle.

The first-ever completely automatic pacemaker, EnPulse offers exclusive features that make it sophisticated yet simple to use.

Boston Scientific ALTRUA family pacemakers deliver benefits of natural pacing, accurately sensing and responding to the body’s signals.

Boston Scientific ALTRUA family pacemakers deliver benefits of natural pacing, accurately sensing and responding to the body’s signals. AV Search Hysteresis reduce unnecessary RV pacing without dropping beats, an MV Blended Sensor restores chronotropic

Boston Scientific ALTRUA family pacemakers deliver benefits of natural pacing, accurately sensing and responding to the body’s signals. AV Search Hysteresis reduce unnecessary RV pacing without dropping beats, an MV Blended Sensor restores chronotropic

Bipolar, active fixation lead for pacemakers, ICDs and CRT systems. Setrox S is an excellent pacing lead with a highly flexible distal end.

The Boston Scientific DEXTRUS lead is intended for placement in either the right atrium or right ventricle. It is designed for an easy lead implant experience with mapping capability, a radiopaque helix and tip extension indicator. The 6.7F active fixation lead features a larger electrical active surface enhancing threshold performance.

Meeting the need of physicians who want the assurance that the atrial lead can sense fine atrial arrhythmias without inappropriately sensing extra-atrial signals, the unique 1.1 mm tip-to-ring spacing of the OptiSense® lead offers a more precise measurement of atrial signals when compared with other atrial leads, which have a spacing of 10 mm or more.Shorter tip-to-ring spacing – 1.1 mm - exclusive lead technology, designed to reduce ventricular oversensing, while maintaining near-field P-wave sensing. Accurate sensing reduces inappropriate mode switching, maintaining A-V synchrony.

The electrically active helix of CapSureFix® Novus lead is designed to extend easily for active fixation and retract for venous passage. The 5076 has a shorter, 10 mm tip-to-ring spacing.

The Atlas™ II and Atlas II+ systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. For Atlas II+ DR and Atlas II+ HF devices, AF Suppression™ pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction.

The Epic II ICDs provide a unique solution that extends, beyond having all the features that are useful in treating the typical patient. These ICDs are built with the extra features to help expect the unexpected, including DeFT Response™ technology and a vibratory patient notifier.Indications & UsageThe Epic® II and Epic® II+ systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias.

At 9.9 mm thin and only 31.5 cc, the TELIGEN ICD is a full-featured device, offering improved safety design and more flexible programming options to help promote appropriate therapy while providing excellent device longevity.

The TELIGEN CRT-D is among the world's smallest and thinnest high-energy devices at 31.5 cc, while less than 10 mm thick. The device offer features based on substantial engineering advances, including extended battery longevity over previous Company devices, self-correcting software and improved programming technology.

BIOTRONIK's Lumax ICD Transmits ECG data automatically with occuring heart rhythm disorders. From remote locations the device informs the physician on critical alteration of the heart rhythm, and immediately delivers an electric shock in case of ventricular fibrillation.

The Virtuoso Family of ICDs with Conexus Wireless Telemetry signals a new era in managing tachycardia. Virtuoso ICDs provide a series of patient benefits; remote patient monitoring with Medtronic CareLink® Network for more efficient chronic disease management, Medtronic CareAlert™ Notification enabling you to quickly identify patients who need attention.

The Concerto cardiac resynchronization therapy device and defibrillator (CRT-D) with Conexus Wireless Telemetry signals a new era in managing heart failure.

The Medtronic InSync II Marquis™ cardiac resynchronization and ICD device offers patient-tailored CRT options and effective ICD protection in conjunction with powerful heart failure management and patient safety features.

InSync Sentry is the world's first CRT-D device with automatic intrathoracic fluid status monitoring, called OptiVol™ Fluid Status Monitoring, that assesses a patient's fluid status by measuring, tracking and reporting intrathoracic impedance.

The Promote RF CRT-D features radiofrequency (RF) telemetry for secure, wireless communication between the implanted device and the programmer, allowing for efficient, more convenient care at implant and follow-up.

At 9.9 mm thin and only 32.5 cc, the COGNIS CRT-D is a full-featured device, offering improved safety design, enhanced diagnostics, and more flexible programming options—while providing excellent device longevity.

The St. Jude Frontier Biventricular Stimulation features a three-port (one atrial and two ventricular) multi-chamber device enabling stimulation of the heart in a biventricular or left-ventricular fashion to promote resynchronization and improved hemodynamic performance in patients with heart failure.

Additionally, the model 5510 device incorporates St.

The Medtronic InSync® III is designed specifically to meet the needs of patients/ candidates for cardiac resynchronization therapy, but who are not indicated for an implantable defibrillator.

Features the smallest tip profile compared to any other lead on the market. The ACUITY™ Spiral LV Lead allows for increased placement options gaining acces to veins previously avaoided. The lead’s unique helical design is intended to maximize vein tissue contact for reliable fixation in a range of vessel sizes and tortuosities.